alexa Metal-Organic Frameworks in Nanotherapeutics: Development of Novel Drug Nanocarriers for Conventional and Nuclear Oncology | OMICS International
ISSN: 2155-983X
Journal of Nanomedicine & Biotherapeutic Discovery

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Metal-Organic Frameworks in Nanotherapeutics: Development of Novel Drug Nanocarriers for Conventional and Nuclear Oncology

Dinorah Gambino*

Professor, Department of Inorganic Chemistry, Montevideo, Uruguay

*Corresponding Author:
Dinorah Gambino
Professor
Department of Inorganic Chemistry
Montevideo, Uruguay
Tel: 5982-9249739
Fax: 5982-9241906
E-mail: [email protected]

Received date: November 19, 2012; Accepted date: November 21, 2012; Published date: November 23, 2012

Citation: Gambino D (2012) Metal-Organic Frameworks in Nanotherapeutics: Development of Novel Drug Nanocarriers for Conventional and Nuclear Oncology. J Nanomed Biotherapeut Discov 2:e120. doi:10.4172/2155-983X.1000e120

Copyright: © 2012 Gambino D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Nanomedicine & Biotherapeutic Discovery

In the search for novel therapeutic approaches that could circumvent recognized drawbacks of conventional therapy against cancer, several systems based on nanoparticles are currently being investigated. Metalorganic frameworks (MOFs) are porous materials that result from the assembly of metal ions or inorganic clusters with polydentate organic linkers. These arrangements lead to porous structures that have been under study during the last years due to their potentiality for different technological applications, like gas storage or purification, catalysis or sensors. The selection of the metal and the linker has significant effects on the structure and properties of the MOF. In recent years these hybrid metal-organic materials have emerged as potential carrier systems for drugs due to their relevant properties for this field, like biodegradability, low toxicity, high and regular porosities, tunable pore size and connectivity, high drug loading capacity, controlled drug release and ability to prolong the drug residence time and to reduce drug toxicity. These properties can be tuned by modifying MOFs structures and porosities. Nanoscale MOFs (NMOFs) are currently under research for the selective delivery of clinical use metal-based antitumor drugs. These materials could be suitable not only as vehicles of conventional organic and metal-based antitumor drugs but also for the development of nanoparticle systems for nuclear oncology or radiotherapy.

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 11693
  • [From(publication date):
    December-2012 - Jun 23, 2018]
  • Breakdown by view type
  • HTML page views : 7924
  • PDF downloads : 3769
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7